These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36063122)

  • 1. Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser.
    Garza-Mayers AC; Su KA; Wiss K
    Pediatr Dermatol; 2022 Nov; 39(6):1005-1006. PubMed ID: 36063122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa.
    Koga H; Hamada T; Ishii N; Fukuda S; Sakaguchi S; Nakano H; Tamai K; Sawamura D; Hashimoto T
    J Dermatol; 2011 May; 38(5):489-92. PubMed ID: 21352278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations.
    Zimmer KP; Schumann H; Mecklenbeck S; Bruckner-Tuderman L
    Gastroenterology; 2002 Jan; 122(1):220-5. PubMed ID: 11781296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Milia as an Isolated Skin Manifestation of Dominant Dystrophic Epidermolysis Bullosa: Evidence of Phenotypic Variability.
    Akasaka E; Nakano H; Takagi Y; Toyomaki Y; Sawamura D
    Pediatr Dermatol; 2017 Mar; 34(2):e106-e108. PubMed ID: 28008652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease.
    Smith BRC; Nyström A; Nowell CJ; Hausser I; Gretzmeier C; Robertson SJ; Varigos GA; Has C; Kern JS; Pang KC
    Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34085701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.
    Nyström A; Buttgereit J; Bader M; Shmidt T; Ozcelik C; Hausser I; Bruckner-Tuderman L; Kern JS
    PLoS One; 2013; 8(5):e64243. PubMed ID: 23717576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.
    Tovar Vetencourt A; Sayed-Ahmed I; Gomez J; Chen H; Agostini B; Carroll K; Parry T; Krishnan S; Sabater AL
    N Engl J Med; 2024 Feb; 390(6):530-535. PubMed ID: 38324486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
    Gayathri E; Anbukkarasi K; Lilly SM
    Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin.
    Aala WJF; Hou PC; Hong YK; Lin YC; Lee YR; Tu WT; Papanikolaou M; Benzian-Olsson N; Onoufriadis A; I Chen Harn H; Hwang DY; Cheng SM; Lu K; Chen PC; McGrath JA; Hsu CK
    Br J Dermatol; 2024 Jul; 191(2):252-260. PubMed ID: 38477474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
    Liu J; Wang L
    Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant pretibial dystrophic epidermolysis bullosa in an Italian family.
    Vaccaro M; Guarneri C; Guarneri F; Lentini M; Cannavò SP
    Pediatr Dermatol; 2020 Nov; 37(6):1207-1209. PubMed ID: 32840914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous dermolysis of the newborn: four new cases and clinical review.
    Radkevich-Brown O; Shwayder T
    Pediatr Dermatol; 2013; 30(6):736-40. PubMed ID: 24117545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo COL7A1 mutation in a patient with trisomy 21: coexistence of dystrophic epidermolysis bullosa and Down syndrome.
    Catalán JA; Rodríguez FA; Yubero MJ; Palisson F; Gana MJ; Krämer SM; Repetto GM
    Int J Dermatol; 2012 Sep; 51(9):1078-81. PubMed ID: 22909362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
    Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H
    J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.